Precision Medicine Market 2025-2035 Industry Forecast : Size, Share, and Market Expansion Analysis | Abbott Laboratories, Kellogg Company, AstraZeneca plc, bioMerieux SA, Cepheid, Myriad Genetics

The Precision Medicine Market accounted for USD 88.2 Billion in 2024 and is expected to reach USD 486.8 Billion by 2035, growing at a CAGR of around 16.8% between 2025 and 2035. Precision medicine, also known as personalized medicine, is an innovative healthcare approach to disease treatment that tailored treatments and interventions according to the individual characteristics such as lifestyle, genetics, and environment. Precision medicine usually offers customized solutions that are based on patients' genetic profiles and disease characteristics. Thus, promising improved outcomes and reduced side effects compared to conventional treatments. The precision medicine market offers genomic sequencing, targeted therapies, diagnostic tools, personalized healthcare devices, bioinformatics software, genetic counseling, and specialized clinical trials.

Get a Sample Copy of This Report :
@ https://www.metatechinsights.com/request-sample/1020

Market Dynamics :
• Advancements in Genomics and Rising Investments for Developing Novel Therapies
• High Cost and Lack of Reimbursement Policies
• Emergence of Targeted Gene Therapy

Industry Experts Opinion:
"Precision medicine offers the potential to tailor treatments to individual patients based on their genetic makeup, environment, and lifestyle, which can significantly improve outcomes and reduce side effects."
• Dr. Francis Collins, Former Director, National Institutes of Health
"Precision medicine is not just about treating diseases; it's about understanding the unique factors that contribute to health and wellness, allowing for more personalized and effective interventions."
• Dr. Robert Green, Professor of Medicine, Harvard Medical School

Segment Analysis
The precision medicine market is driven by key technologies such as bioinformatics, drug discovery, gene sequencing, and companion diagnostics, with drug discovery being the dominant segment. Precision medicine is revolutionizing clinical trials by tailoring treatments based on genetic and molecular profiles, improving the effectiveness of therapies, particularly in oncology.
Regional Analysis
North America, with its advanced healthcare infrastructure, regulatory support, and research emphasis, dominates the precision medicine market. Europe and Asia Pacific are also growing, with Asia Pacific expected to experience the fastest growth due to increased investments and genomic research advancements.
Competitive Landscape
Leading players in the precision medicine market include F. Hoffmann-La Roche, Siemens, Janssen Global Services, Illumina, Quest Diagnostics, and 23andMe. Siemens is enhancing cancer care with advanced imaging and AI analytics, while Janssen focuses on personalized therapies, especially in oncology, immunology, and neuroscience, leveraging AI and genomic sequencing.
Report Coverage:
By Technology
• Big Data Analytics
• Bioinformatics
• Gene Sequencing
• Drug Discovery
• Companion Diagnostics
By Indication
• Oncology
• CNS
• Immunology
• Respiratory diseases
• Genetic disorders
• Skin diseases
• Others
By Application
• Diagnostics
o Genetic Tests
o Biomarker Based Tests
o Esoteric Tests
• Therapeutics
o Inhibitor Drugs
o Monoclonal Antibodies
o Cell & Gene Therapy
o Antiviral & anti-retroviral Drugs
o Others
By End-user
• Hospitals
• Diagnostic Laboratories
• Others
By Region
North America
• U.S.
• Canada
Europe
• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific
Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC Countries
• South Africa
• Rest of the Middle East & Africa

Get a Customization Report :
@ https://www.metatechinsights.com/customize-report/1020

List of Companies:
• Abbott Laboratories, Inc
• Abbvie, Inc.
• AstraZeneca plc
• bioMerieux SA
• Bristol-Myers Squibb Company
• Cepheid (Danaher Corporation)
• Eli Lilly & Company
• F. Hoffmann-La Roche
• GlaxoSmithKline plc
• Laboratory Corporation of America Holdings (Covance Inc.)
• Myriad Genetics, Inc.
• Novartis AG
• Pfizer, Inc.
• QIAGEN N.V.
• Quest Diagnostics
• Takeda Pharmaceutical Company Limited
• Thermo Fisher Scientific Inc.
• Vyant Bio, Inc. (Cancer Genetics, Inc.)
• GRAIL
• Guardant Health

Inquiry Before Buying :
@ https://www.metatechinsights.com/inquiry-before-buying/1020

Frequently Asked Questions (FAQs)
What is the Precision Medicine Market size in 2024 and how it will evolve through 2035?
What are the key growth opportunities in Precision Medicine Market?
Which are the largest and fastest-growing segments in Precision Medicine Market and how much revenue will each segment account for in 2035?
Which region will make a notable contribution to the Global Precision Medicine Market?
Who are the leading players operating in the global Precision Medicine Market?

Address :
50 MacAleese Lane #24, Moncton, New Brunswick, E1A 3L9, Canada

Contact Us:
Web: www.metatechinsights.com
Ph: US - +1 5064 048 481
Email: sales@metatechinsights.com

About Us:
Metatech Insights specializes in making comprehensive global and regional market research reports in Healthcare, Medical Devices, Healthcare IT, Agriculture, Chemicals and Materials, Consumer Goods, Food & Beverages, Pet Care, Cryptocurrency, and Novel technologies. Our meticulously designed research reports are regarded as one of the most detailed and well-thought market research studies available in the industry. Our reports typically include market assessments, analysis of industry trends, and competitive intelligence.

This release was published on openPR.